I agree, the possibility of LYMPRO if it receives
Post# of 30028
Posted On: 08/25/2014 10:38:35 AM
I agree, the possibility of LYMPRO if it receives a good test result from the bridge study from BD, we may sell it off for a percentage of the revenues to focus on MANF, It would be a great influx of capital and may reduce the headache of a diagnostic division.
WD
WD
(0)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼